Business & Finance
AbbVie to pay higher dividend and authorises new stock repurchase plan
16 February 2018 -

The board of directors of AbbVie (NYSE:ABBV), a biopharmaceutical company, declared on Thursday its quarterly dividend of USD0.96 per share of its stock.

This 35% higher cash dividend is due on 15 May 2018 to stockholders of record at the close of business on 13 April 2018.

Since the company's inception in 2013, AbbVie has increased its dividend by 140 percent.

In addition, the company has approved a new USD10bn stock repurchase programme in open market or private transactions, has no time limit and may be discontinued at any time. The purchases may be made from time to time in management's discretion.